| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Real Estate > Real Estate > Insider's Corporate Relocation Glossary. |
|
E-Articles - Insider's Corporate Relocation Glossary.
Is not that you don't have enough to do, moving your career, family, and home. Corporate relocation is big business and has tried and true procedures and jargon. Here are some of the words you'll hear once you're in the According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product process. Amended value: The actual sale price after the seller successfully markets and sells his or her home through the broker of his or her choice. The sale is turned over to a third-party relocation company for clos ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ng, and the guaranteed offer is amended or changed. Appraised price (AP): The price the third-party relocation company offers (under most contracts) the seller for his or her property. Generally, the average of two or m lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. re independent appraisals. Broker’s market analysis (BMA): The real estate broker’s opinion of the expected final net sale price, determined after acquisition of the property by the third-party company. Broker’s price here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe pinion (BPO): The real estate broker’s opinion of the expected final net sale price, determined prior to the acquisition of the property. Competitive/comparative market analysis (CMA): The analysis used to provide marke d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro t information to the seller and assist the real estate broker in securing the listing. Carrying costs: Cost incurred to maintain a property (taxes, interest, insurance, utilities, and so on). Corporate client: The comp ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ny with whom the third-party relocation company has an agreement to handle the relocating employees. Contract of sale: The agreement between the third-party relocation company and the seller (transferee) whereby the thi easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi d- party company purchases the property owned by the seller. Destination services: Services provided to the transferee at the new location. They can include familiarization tours, temporary housing, school searches, and nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically so on. Direct home selling costs (DHSC): Carrying costs, loss on sale, repairs and improvements, commission, closing costs, principal, interest, taxes and insurance, interest on equity loans, and utilities. DOM: Days o and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ n market. Gross sale price: The sale price before any concessions. Guaranteed offer: The amount, after appraisals, the employer offers the transferring employee for his or her property. Home-finding assistance: Additi ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi nal assistance provided by a third-party relocation company that can include information about the destination community. Inspection rider: A rider to the purchase agreement between the third-party relocation company an ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a the buyer of the transferee’s property stating that property is being sold “as is.” All inspection reports conducted by the third-party company are disclosed to the buyer, and it is the buyer’s duty to do his or her own dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod inspections and tests. Inventory: A transferee’s property the third-party relocation company has acquired. List date: The actual date the property was listed with the current broker. List price: The current list price cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin of the property. Listing exclusion: A clause included in the listing agreement when the seller (transferee) lists his or her property with a broker. Market familiarization trip: A visit by the transferee to the new lo tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ation to view housing market options and location highlights. Marketing period: The period of time in which the transferee may market his or her property (typically 45, 60, or 90 days) as directed by the third-party com t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel any’s contract with the employer. Net sales price: Gross sales price minus concessions to the buyers. Property or home-finding assistance status reports: Reports filed weekly or monthly by the listing or buying agent r ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust presenting the transferee. R & I: Estimated and actual repair and improvement costs. Relist: Property that was listed with another broker but relisted with the current broker. Temporary housing: Housing that the trans y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products feree occupies until permanent housing is selected or becomes available. Third-party company: A relocation company hired by the employee’s employer to coordinate the employee’s move to a new location. Trailing spouse: . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de he spouse or partner of the employee being moved to a new location by an employer. Transaction management fee (TMF): A fee charged by listing brokers to the seller as part of the listing agreement. Vacate date: The dat elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip on which the seller (transferee) vacates the property (generally the date when responsibility for property expenses by the transferee ends) and the third-party company assumes ownership for the property through a buyout tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Profitable Online Business - Intermediate Tips for Excel at Online Business Five Simple Steps for Developing A Successful Internet Business Become a Millionaire - Your Next Great Chance!
|